|
|
Volumn 32, Issue 2, 2014, Pages 119-
|
|
Setback for JAK2 inhibitors.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
JANUS KINASE 2;
PROTEIN KINASE INHIBITOR;
PYRAZOLE DERIVATIVE;
RUXOLITINIB;
CLINICAL TRIAL (TOPIC);
DRUG INDUSTRY;
HUMAN;
MYELOID METAPLASIA;
NOTE;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
HUMANS;
JANUS KINASE 2;
PRIMARY MYELOFIBROSIS;
PROTEIN KINASE INHIBITORS;
PYRAZOLES;
|
|
EID: 84907197655
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0214-119a Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|
